ArticleInternational journal of nanomedicine2015

Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors.

Huali Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.